Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. is a registered legal entity registered in China, and its current status with SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) is active. Its registered address on file is Shijiazhuang, China. 1 shareholder is on record for Hebei Changshan Biochemical Pharmaceutical Co., Ltd., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) and was last updated on 25 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
1
Shareholders of Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
One shareholder is currently on record for Hebei Changshan Biochemical Pharmaceutical Co., Ltd., held on the capital contribution filing on the National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), filed under the Company Law of the PRC. The largest of these is DFA Emerging Markets Core Equity Portfolio, holding 100% — a majority holding. Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| DFA Emerging Markets Core Equity Portfolio | 100% | SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) |
Officers
13
Directors and officers of Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
The Chairman Of The Board & Gm of Hebei Changshan Biochemical Pharmaceutical Co., Ltd. currently on record is Xiaodong GAO; 13 officers are currently on record for Hebei Changshan Biochemical Pharmaceutical Co., Ltd., filed with SAMR — public search via GSXT (National Enterprise Credit Information Publicity System). Management authority at Hebei Changshan Biochemical Pharmaceutical Co., Ltd. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control. The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Hebei Changshan Biochemical Pharmaceutical Co., Ltd.?
One shareholder is currently on record for Hebei Changshan Biochemical Pharmaceutical Co., Ltd., held on the capital contribution filing on the National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), filed under the Company Law of the PRC. The largest of these is DFA Emerging Markets Core Equity Portfolio, holding 100% — a majority holding. Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is Hebei Changshan Biochemical Pharmaceutical Co., Ltd.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for Hebei Changshan Biochemical Pharmaceutical Co., Ltd. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does Hebei Changshan Biochemical Pharmaceutical Co., Ltd. have on record?
1 shareholder is shown on record for Hebei Changshan Biochemical Pharmaceutical Co., Ltd..
Is Hebei Changshan Biochemical Pharmaceutical Co., Ltd. still an active company?
Hebei Changshan Biochemical Pharmaceutical Co., Ltd.'s status on SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) is listed as active.
What is Hebei Changshan Biochemical Pharmaceutical Co., Ltd.'s registered address?
The registered address on file for Hebei Changshan Biochemical Pharmaceutical Co., Ltd. is Shijiazhuang, China.
Who are the officers/directors of Hebei Changshan Biochemical Pharmaceutical Co., Ltd.?
The Chairman Of The Board & Gm of Hebei Changshan Biochemical Pharmaceutical Co., Ltd. currently on record is Xiaodong GAO; 13 officers are currently on record for Hebei Changshan Biochemical Pharmaceutical Co., Ltd., filed with SAMR — public search via GSXT (National Enterprise Credit Information Publicity System). Management authority at Hebei Changshan Biochemical Pharmaceutical Co., Ltd. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Can Zavia monitor changes to Hebei Changshan Biochemical Pharmaceutical Co., Ltd.'s ownership over time?
This profile reflects a point-in-time snapshot from SAMR — public search via GSXT (National Enterprise Credit Information Publicity System). Zavia's monitoring API can track changes to Hebei Changshan Biochemical Pharmaceutical Co., Ltd.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Hebei Changshan Biochemical Pharmaceutical Co., Ltd.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including China, so records like Hebei Changshan Biochemical Pharmaceutical Co., Ltd.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) and was last synced on 25 September 2026.